Author: Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E.
Description: Low-grade inflammation is the hallmark of metabolic disorders such as obesity, type 2 diabetes and nonalcoholic fatty liver disease. Emerging evidence indicates that these disorders are characterized by alterations in the intestinal microbiota composition and its metabolites, which translocate from the gut across a disrupted intestinal barrier to affect various metabolic organs, such as the liver and adipose tissue, thereby contributing to metabolic inflammation. Here, we discuss some of the recently identified mechanisms that showcase the role of the intestinal microbiota and barrier dysfunction in metabolic inflammation. We propose a concept by which the gut microbiota fuels metabolic inflammation and dysregulation.
Subject headings: Animals; Chronic Disease; Dysbiosis; Gastrointestinal Microbiome; Humans; Inflammation; Intestinal Mucosa; Metabolic Diseases; Gut
Publication year: 2020
Journal or book title: Nature Reviews. Immunology
Volume: 20
Issue: 1
Pages: 40–54
Find the full text: https://www.nature.com/articles/s41577-019-0198-4
Find more like this one (cited by): https://scholar.google.com/scholar?cites=15006946852812890254&as_sdt=1000005&sciodt=0,16&hl=en
Type: Journal article
Serial number: 3133